Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

Share Price is delayed by 15 minutes
Get Live Data
499.80    -0.20 (-0.04%)
Bid:
499.60
Ask:
500.50
Spread: 0.90 (0.18%)
Market Cap: £1.35b
CHG Live PriceLast checked at - London Stock Exchange

Intraday Chemring Share Chart

CONTRACT AWARDS

28 Mar 2013 14:05

RNS Number : 1634B
Chemring Group PLC
28 March 2013
 



FOR IMMEDIATE RELEASE 28 MARCH 2013

CHEMRING GROUP PLC

ALLOY SURFACES AND KILGORE FLARES AWARDED $26 MILLION COUNTERMEASURES CONTRACTS BY THE US DEPARTMENT OF DEFENSE

Chemring Group PLC ("Chemring") is pleased to announce that its US subsidiaries, Alloy Surfaces Company, Inc. and Kilgore Flares Company LLC, have been awarded contracts worth $26 million for the manufacture of M211, M206, MJU-7A/B and MJU-10/B decoy devices for the US Army and the US Air Force. Deliveries under the contracts are scheduled to begin in June 2013 and will continue into 2015. The M211 decoy order is valued at $6 million, and will be produced at Alloy Surfaces. The M206, MJU-7A/B and MJU-10/B contracts are valued at $20 million, and will be produced at Kilgore Flares.

Mark Papworth, Chief Executive of Chemring, commented: "We are very pleased to receive these contracts from the US Army and the US Air Force, which demonstrates their continued confidence and trust in our countermeasures. We are very proud to deliver the highest quality infra-red decoys to the US Department of Defense and our international customers."

The US Army and US Air Force use these decoys to protect all of their helicopters, and transport and fighter aircraft against man-portable air defense systems, commonly known as MANPADS.

-ENDS-

Chemring Group PLC

Rupert Pittman - Group Director of Communications and Investor Relations

01489 881880 / rupertp@chemring.co.uk

MHP Communications

Andrew Jaques / James White

0203 128 8100

Notes to Editors:

Chemring is a market leading manufacturing business supplying high technology electronics and energetic products to over sixty countries around the world. Chemring has a diverse portfolio of products that predominantly protect military people and platforms, providing insurance against a constantly changing threat. These range from countermeasures to protect aircraft, to ground penetrating radar to protect troops and vehicles from improvised explosive devices. Alloy Surfaces and Kilgore Flares are industry leaders in the design, development, and production of F-22, JSF and covert multi-spectral special material decoys. 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTSEEFDAFDSEID
Date   Source Headline
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSTotal Voting Rights
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSTransaction in Own Shares
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20253:52 pmRNSHolding(s) in Company
17th Nov 20257:00 amRNSTransaction in Own Shares
14th Nov 20257:16 amRNSDirector Declaration
10th Nov 20257:00 amRNSHolding(s) in Company
10th Nov 20257:00 amRNSPost-close and contract wins update
3rd Nov 20257:00 amRNSAppointment of Joint Corporate Broker
3rd Nov 20257:00 amRNSTotal Voting Rights
9th Oct 20252:54 pmRNSHolding(s) in Company
1st Oct 20257:00 amRNSTotal Voting Rights
9th Sep 202510:24 amRNSDirector/PDMR Shareholding
9th Sep 20259:55 amRNSHolding(s) in Company
1st Sep 20257:00 amRNSTotal Voting Rights
20th Aug 20253:49 pmRNSHolding(s) in Company
12th Aug 20252:02 pmRNSHolding(s) in Company
12th Aug 20257:00 amRNSAdditional Listing
1st Aug 20257:00 amRNSTotal Voting Rights
1st Jul 20257:00 amRNSTotal Voting Rights
30th Jun 20257:00 amRNSAcquisition of Landguard Systems
26th Jun 20257:00 amRNSNorwegian feasibility study
18th Jun 20257:00 amRNSBlock listing Interim Review
18th Jun 20257:00 amRNSBlock listing update
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSDirectorate Change
3rd Jun 20257:00 amRNSInterim Results
1st May 20259:15 amRNSTotal Voting Rights
29th Apr 20257:00 amRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20257:00 amRNSTransaction in Own Shares
24th Apr 20257:00 amRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:00 amRNSTransaction in Own Shares
17th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.